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The association between erythema multiforme (EM) and 
herpes simplex virus (HSV) infection has long been appre-
ciated, although the exact role which HSV may play in the 
pathogenesis of this herpes-associated EM (HAEM), is un-
known. Previous studies have suggested, but not definitively 
demonstrated, the presence ofHSV in lesions of HAEM. The 
presence of HSV would support the hypothesis that an im-
mune-mediated response directed against HSV -specific anti-
gens in the skin is central to lesion development in HAEM. 
The purpose of this study was to examine lesions of EM for 
the presence of HSV DNA by using the polymerase chain 
reaction (PCR) . In addition, in situ hybridization using an 
HSV-specific RNA probe was performed to further localize 
the HSV nucleic acids within the skin. 
DNA was extracted from formalin-fixed, paraffin-embed-
ded specimens of cutaneous lesions of HAEM and also from 
EM for which no precipitating factor could be documented, 
Erythema multi forme (EM) has captured the imagination of dermatologists for well over a century with its strik-ing clinical presentation of symmetrically distributed, polymorphous lesions ranging from macules and pa-pules to annular plaques, bullae and characteristic tar-
gets. Nevertheless, the pathogenesis of this acute, self-limited, 
often-recurrent disorder remains unclear. Likewise, the association 
of EM with an antecedent herpes simplex virus (HSV) infection has 
long been appreciated, but the mechanism by which HSV infection 
might lead to EM has yet to be defined. 
EM has been classified as a hypersensitivity phenomenon or 
"reactive erythema," potentially precipitated by multiple factors, 
primarily drugs or infectious agents. Certainly the most common 
and best documented of these factors is HSV, both types 1 and 2. 
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otherwise known as idiopathic EM (IPEM). DNA from le-
sions of bullous pemphigoid served as a negative control. 
Using PCR to specifically amplify HSV sequences which 
might be present, and then performing Southern analysis, we 
demonstrated HSV DNA in 9/13 HAEM and 6/9 IPEM 
biopsies. No HSV was detected in six lesions of bullous pem-
phigoid. In situ hybridization of three cutaneous HAEM le-
sions using an 35S-labeled HSV-specific RNA probe localized 
the HSV nucleic acids predominantly to the epidermis. 
Three biopsies of chronic dermatitis, used as negative con-
trols, did not demonstrate this specific hybridization. These 
findings confirm the presence of HSV in lesions of HAEM 
and are consistent with the concept of an HSV -specific im-
mune-mediated pathogenesis for this disease. In addition, 
most cases of IPEM appear to be herpes associated despite the 
absence of clinically apparent HSV infection.] I,west Dermatol 
93:183-187,1989 
Herpes-associated EM (HAEM) typically develops within three 
weeks following infection with HSV, and will often recur in these 
individuals with subsequent episodes of recurrent herpes infection. 
An estimated 15% to 63% of all cases of EM are secondary to HSV 
[1]. and it has been suggested that most cases of so-called idiopathic 
EM (IPEM) are related to subclinical HSV infection [2,3] 
Although there are several case reports of HSV being isolated 
from lesions of EM [4,5] , viral cultures from EM lesions are usually 
negative. However, other indirect evidence for the role of HSV in 
the pathogenesis of HAEM includes the detection ofHSV antigens 
in circulating immune complexes in patients with HAEM [6], viral 
particles seen by electron microscopy [4], and the demonstration of 
HSV-specific antigens in skin lesions of HAEM by immunofluores-
cence [7]. 
Recently, newer molecular biology techniques have made it pos-
sible to detect and to study specific nucleic-acid sequences which 
may be present in cells or tissue. One such technique is the polymer-
ase chain reaction (PCR) [8]. Briefly, the PCR involves repeated 
cycles of three steps. The experimental DNA, referred to as the 
template, is combined with a thermostable DNA polymerase (Taq 
polymerase), nucleotides, and short oligonucleotide primers. The 
primers are selected and synthesized to be complimentary to the 
regions of the DNA template flanking the segment of interest. In 
the first step, the sample is denatured at a high temperature. This is 
followed by rapid cooling to allow the second step, annealing of the 
primers to occur. In the third step, the temperature is rapidly in-
creased again for extension of the primers, resulting in replication of 
the DNA sequence of interest. These three steps are repeated multi-
ple times, amplifying that portion of the template between and 
including the primer sites. Using the PCR, DNA which was ini-
tially present in minute quantities, may be specifically amplified to 
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readily detectable levels amidst the milieu of cells in culture, or 
tissue specimens, even when formalin-fixed and paraffin-embedded 
[9,10). 
The purpose of this study was to examine lesions of EM for the 
presence of HSV DNA using the PCR. In addition, in situ hybridi-
zation using an HSV-specific 35S RNA probe was performed to 
further localize the HSV nucleic acids within the skin . . 
METHODS 
Selection of Tissue For this study, EM was defined by the follow-
ing criteria: an acute, self-limited (less than six weeks), cutaneous or 
mucocutaneous illness; the presence of symmetrically distributed, 
discrete, round, fixed (lasting more than seven days), erythematous 
skin lesions; concentric color changes in at least some lesions (target 
lesions); and compatible histopathologic findings (primarily mono-
nuclear cell infiltrate, no leukocytoclastic vasculitis). HAEM was 
defined as EM occurring within three weeks of a recurent HSV 
infection. IPEM was defined as EM for which no precipitating 
factor could be determined, specifically no history ofHSV infection 
or drug ingestion within three weeks. Biopsies were taken from 
cutaneous EM lesions, fixed in formalin, and embedded in paraffin. 
For the PCR, a total of13 HAEM and 9 IPEM biopsies were studied. 
All HAEM biopsies, and 5/9 IPEM biopsies were obtained during 
episodes of recurrent disease. A confirmed history of recurrent dis-
ease was not available for the remaining four IPEM biopsies. Speci-
mens utilized as controls included: six lesions of bullous pemphi-
goid, tissue infec~ed with HSV-1 and HSV-2, and tissue infected 
with other herpes viruses (varicella-zoster virus, cytomegalovirus, 
and Epstein-Barr virus). Formalin-fixed, paraffin-embedded biop-
sies were also utilized for in situ hybridization and included three 
lesions of HAEM, three lesions of chronic dermatitis and one lesion 
of herpes labial is. 
Extraction of DNA from Tissue for Use in PCR DNA was 
extracted from each tissue block, as previously described [9,10] with 
minor modifications. Twenty-five 5-um sections were cut from 
each block, de-paraffinized in xylene, and rinsed with 95% ethanol. 
After drying, the tissue pellets were resuspended in TE (10 mM 
Tris-HCl, 1 mM EDTA, pH 7.8) and incubated with Proteinase K 
overnight at 37°C. The samples were incubated for ten minutes at 
95°C, spun, and the supernatants retained for use in the PCR. 
The Polymerase Chain Reaction Twenty-two base oligonu-
cleotide primers which flank and amplify a 92 base pair portion of 
the HSV genome coding for DNA polymerase were synthesized. 
These primers were previously demonstrated to be specific for 
HSV -1 and HSV -2, with no cross-reaction with the other herpes-
viruses (10). Primers coresponding to the human beta-globin gene 
(BG) were used for control reactions to verify the quality of experi-
mental DNA extracted from the tissue blocks, as previously de-
scribed [11). These primers amplify a 110-bp DNA sequence. The 
PCR was performed according to standard technique [11] with 
template DNA, Taq polymerase (New England BioLabs, Beverly, 
MA), NEB Buffer (New England BioLabs), dNTPs (Boehringer 
Mannheim, Indianapolis, IN) , and primers. For each tissue speci-
men, the PCR was performed using half of the extracted DNA 
together with the HSV primers, and the other half with the BG 
primers. Thirty cycles were performed using the DNA ~hennal 
Cycler (Perkin-Elmer Cetus Instruments, Norwalk, CT) With tem-
peratures for denaturation, annealing, and elongation at 94°C, 
51 ° C, and 72 ° C, respectively. . 
Detection of Amplified DNA Following the PCR, the DNA 
samples were separated on an 8% po.'yacrylami~e gel ~long with 
size markers. The DNAs were first vlsuahzed With etiudlUm bro-
mide and ultraviolet light and then electrophoretically transferred 
from the gel to a ZetaProbe filter (BioRad, Richmond, CA) . Oli-
gonucleotides complimentary to an inner portion of the DN.A se-
quence amplified during the PCR for both the HSV and BG pnmers 
were synthesized. In each case, this "internal oligonucleotide" cor-
responded to an inner portion of the amplified sequence, not over-
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lapping any part of the primer sequences. Both HSV and BG inter-
nal oligonucleo tides were end-labeled using gamma 32p ATP 
(Amersham, Arlington Heights, IL) and T4 polynucleotide kinase, 
as described [12) . The Zeta Probe filters were pre-hybridized in hy-
bridization buffer (6XSSC, 5XDenhardt's, 100 ug/ml tRNA, 100 
ug/ml .salmon sperm DNA, 1 % SDS) for four hours and then hy-
bridized overnight at 50°C in this same buffer with both labeled 
internal oligonucleotides (1 X 106 cpm/ml) . The filters were 
washed to a stringency of 2XSSC/l % SDS at 50°C and then ex-
posed to Kodak XAR film for three hours and overnight. 
In Situ Hybridization Three HAEM biopsies were selected for 
in situ hybridization. Three biopsies of chronic dermatitis and a 
biopsy of herpes labialis served as negative and positive controls, 
respectively. In situ hybridization was performed, as previously de-
scribed (13), with minor modification. Briefly, 5-um sections of 
tissue were baked on gelatin-coated glass slides, deparaffinized in 
xylene, incubated in 0.2 N HCl, followed by 5 mg/ml Pronase, and 
refixed in 4% paraformaldehye. An 35S-labeled RNA probe was 
prepared by standard in vitro transcription of a cloned 2.3 kb frag-
ment of HSV -1 corresponding to that portion of the HSV genome 
coding for the viral envelope glycoprotein B. This probe was pre-
viously demonstrated to be specific for HSV -1 and HSV -2, with no 
cross-hybridization with other herpesviruses or with mammalian 
DNA [14). Since this was the anti-sense transcript, both mRNA and 
DNA cou ld potentially be detected. The probe was suspended in 
hybridization buffer (50,000 cpm/20 ul), placed over the tissue 
sections, and covered by glass coverslips sealed with rubber cement. 
The probe and tissue sections were denatured at 95 ° C for 15 min, 
and hybridization continued overnight at 42°C. The slides were 
washed to a maximum stringency ofO.5X SSC, 1 mM EDTA, 2.5 
uM DTT at 68°C, dipped in Kodak NTB-2 emulsion, exposed for 
two to three weeks and then developed. Sections were stained with 
hematoxylin and eosin and examined by light microscopy. As an 
additional negative control, a second 35S-labeled RNA probe corre-
sponding to a portion of a rat acetylcholine receptor (ACH) gene 
was used for in situ hybridization with each of these tissue speci-
mens. This ACH probe was comparable in size and specific activity 
to the HSV probe. 
RESULTS 
Detection of Amplified DNA On visualizing the DNA on the 
gels with ethidium bromide, bands of the anticipated size for the 
amplified HSV and BG fragments were readily detected, although 
in some cases background bands made conclusive interpretation 
difficult. However, by Southern analysis with the labeled internal 
oligonucleotides, either no signal was seen or a single, unambiguous 
band in the anticipated location for each primer was seen in each 
lane. These results are given in Table I and representative specimens 
illustrated in Figure 1. Amplification with the BG primers occurred 
with all specimens. Amplification with the HSV primers was seen in 
9/13 HAEM and 6/9 IPEM. Fifty percent of the HSV positive 
IPEM biopsies were obtained from patients with known recurrent 
disease, and 50% from IPEM patients for whom a confirmed history 
of recurrence was not available. Not included within these results or 
in Table I is a second biopsy from one patient with recurrent IPEM, 
ohtained during a subsequent episode of EM. HSV was detected in 
both biopsies from this patient. A very strong amplification was seen 
for both HSV-1 and HSV-2 with the HSV primers. No amplifica-
tion was seen with the HSV primers for the bullous pemphigoid 
lesions or tissue infected with other herpesviruses. 
Table I. 
Tissue Tested 
HAEM 
IPEM 
BP 
Detection of HSV Using the Polymerase Chain 
Reaction 
HSV Positive/Total 
9/13 (69%) 
6/9 (67%) 
0/6 (0%) 
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BG 110 bp 
HSV 92 bp 
HSV HAEM IPEM BP 
Figure 1. Southern analysis of DNA amplified by the peR. DNA in the 
first lane of each pair was amplified with the HSV primers, whi le D NA in 
the second lane of each pair was amplified with the BG primers. Using 32p_ 
labeled internal oli gonucleotides to detect the amplified DNA, BG is dem-
onstrated in all specimens. HSV DNA is demonstrated within lesions of 
herpes labialis (HSV) , HAEM and IPEM, but not within BP. 
In Situ Hybridization Hybridization of the HSV probe was de-
tected primarily within the epidermis in herpes labialis and all three 
lesions of HAEM. In each case, diffuse epidermal staining, as well as 
focal areas of what appeared to be perinuclear accentuation were 
appreciated. These two patterns of staining are illustrated in Figure 
2. Within the lesions of chronic dermatitis, slight background bind-
ing was present uniformly over the specimens, but no specific hy-
bridization with the HSV probe was detected (Fig 2C). Using the 
ACH probe, no specific hybridization was seen with any of the 
tissue specimens (not shown). 
DISCUSSION 
HAEM is by far the most-common subset of EM, occurring primar-
ily in young, healthy adolescents and adults, the age group in which 
frequent recurrences ofHSV would be anticipated. HAEM is almost 
always manifested as EM minor [2]. namely cutaneous lesions of 
severa l weeks' duration, with limited mucosal, usually oral, in-
volvement. The lesions typically develop from three to 21 days 
following herpes infection, and this time delay appears to be quite 
constant for each individual [1] . Recurrences are frequent, although 
they do not necessarily follow each episode of herpes infection, nor 
does a clinically apparent episode of herpes always antedate the EM. 
Bateman is given credit for being the first to recognize an associa-
tion between HSV and EM as early as 1813 [15]. Since that time, 
support for this association, based on clinical grounds, has been 
well-established [2]. Currently, the efficacy of acyclovir in sup-
pressing lesions of recurrent HSV and the subsequent EM [1 6] is 
further evidence of an etiologic relationship. However, exactly 
what role HSV plays in the pathogenesis of HAEM remains unclear. 
Attempts to demonstrate conclusively HSV in HAEM lesions have 
met with little success. Viral cultures from HAEM have been almost 
uniformly negative. In the few cases where HSV isolation has been 
reported [4,5], the patients were genera ll y immunocompromised 
with extensive cutaneous disease. An individual instance in which 
viral particles were detected within HAEM lesions by electron mi-
croscopy has been reported [4]. Recently, Orton et al [7] provided 
the most compelling evidence to date by using indirect immunoflu-
orescence to demonstrate the presence of HSV-specific antigens 
within the epidermis of HAEM lesions. 
Despite these findings, the pathogenesis of EM, including 
HAEM, remains a matter of speculation, although immune me-
diated mechanisms are almost certainly involved. Most evidence 
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Figure 2. Tn situ hybridization using the HSV-specific RNA probe. The 
epidermis of a lesion of herpes labialis shows specific hybridization with 
some increase overlying nuclei (A). A more difI'use pattern of specific 
hybridization is seen within the epidermis of a lesion of HAEM (B) . No 
specific hybridization is detected in a lesion of chronic dermatitis (C). 
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currently points toward a cell-mediated immune process, probably 
directed against pertinent antigens (e.g., HSV) present locally in the 
skin. The histopathology of EM lesions in various stages of evolu-
tion is consistent with this possibility. Early changes include endo-
thelial cell swelling; a mild perivascular, mononuclear cell infil-
trate; and scattered epidermal cell necrosis followed later by a 
progressive increase in the number of inflammatory cells with exo-
cytosis, liquefaction degeneration, and extensive epidermal damage 
[17,18]. The inflammatory infiltrate consists of monocyte/macro-
phages and T lymphocytes of both the helper and suppressor type, 
compatible with a delayed-type hypersensitivity reaction [18,19]. In 
addition, keratinocytes in EM lesions express HLA-DR which is 
seen in a variety of cell-mediated immune reactions as a result of 
stimulation by gamma interferon released by activated T cells [19]. 
An immune-complex (Ie) mediated pathogenesis has also been 
proposed based on the presence ofICs in the serum and blister fluid 
[20,21] and immunoreactants within the dermal blood vessels and 
along the dermo-epidermal junction in early HAEM lesions [22]. 
However, the vasculitis and neutrophilic infiltrate typically present 
with IC disease is not seen in EM. Also inconsistent with IC disease 
is the lack of involvement of organs other than the skin. 
In this study, we have demonstrated the presence ofHSV DNA in 
lesions of HAEM and in IPEM, confirming results of earlier studies 
in which this possibility was suggested. The HSV appears to be 
localized primarily within the epidermis, as demonstrated by in situ 
hybridization. This lends further support to the concept that an 
immune-mediated response directed specifically to HSV in the skin 
is the primary mechanism in HAEM lesion development. In addi-
tion, these current findings may also have broader implications in 
terms of the relationship of HSV and its human host, including 
potential "latency" within the epithelium. 
To screen all of the tissue specimens included in this study for the 
presence of HSV, we used a newly described technique called the 
polymerase chain reaction. This technique has a very high degree of 
specificity determined both by the primers utilized during the am-
plification and by the internal oligonucleotide used for detection of 
the amplified product [8]. Also, because of the exponential amplifi-
cation of the DNA sequence of interest, the sensitivity is higher 
than that previously available by any other method [8]' However, a 
disadvantage to the PCR in this setting is that the exact location of 
the HSV within the skin cannot be determined using this technique 
alone. The HSV could be present within cells native to the skin, 
such as keratinocytes and endothelial cells, and/or within cells 
present on a transient basis, as in the inflammatory infiltrate, an 
important distinction in terms of the pathogenesis of this disease 
process. For this reason, we also performed in situ hybridization on 
representative tissue samples. Based on the results of this protedure, 
the HSV nucleic acids within lesions of HAEM appear to be primar-
ily epidermal in location, consistent with the location of HSV -spe-
cific antigens previously reported [7]. 
Focusing now on the pathogenesis of HAEM, although similar 
processes might also occur in other forms of EM, we propose that 
lesion development is the result of a cell-mediated immune response 
directed against HSV present in the skin, primarily within the epi-
dermis. However, this possibility raises a number of questions. How 
does the HSV reach the multiple sites where HAEM lesions de-
velop? In what form does the virus exist in the skin? Does it remain 
there between episodes of EM? Why do only certain individuals 
with recurrent HSV infection develop HAEM? Hematogenous 
spread during primary HSV infection or with recurrent episodes of 
HSV would be a possible mode of dissemination to the skin [23]. 
The fact that HAEM lesions tend to recur in the same location in a 
given individual would suggest that the virus remains in the skin in 
an immunologically quiescent state or within innervating neurons 
for that cutaneous site between EM episodes. Evidence suggesting 
that continuous movement of virus between the epithelium and 
nervous system at a subclinical level may occur [24] further supports 
this concept. Some viral protein production must occur to permit 
HSV antigen expression, but viral replication consistent with an 
active infection would not appear to occur except in immunocom-
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promised patients. A recent study demonstrating a strong associa-
tion of HAEM, but not recurrent HSV alone, with the HLA DQw3 
suggests a possible HLA related altered immune response to HSV in 
individuals who develop HAEM [3]. The answers to the questions 
posed here are, of course, only speculative, and additional investiga-
tion :will be necessary to confirm or refute their validity. Of particu-
lar importance will be to determine whether or not HSV is present 
in the peripheral blood cells of HAEM patients on a continuous or 
sporadic basis, and whether HSV can be detected in normal skin of 
HAEM patients during an active episode, or in previously involved 
skin between active episodes of HAEM. 
In summary, in this study we have demonstrated the presence of 
HSV DNA within cutaneous lesions of HAEM and IPEM, and the 
HSV appears to be in a predominantly epidermal location. These 
findings are consistent with the premise that an immune mediated 
response directed against HSV present in the epidermis is involved 
in the pathogenesis of HAEM. In addition, most cases of "idio-
pathic" EM appear to be herpes associated despite the absence of 
clinically apparent HSV infection. 
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